Sotera Health (SHC) EBIT Margin (2020 - 2026)

Sotera Health (SHC) has reported EBIT Margin for 7 consecutive years, with 28.16% the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT Margin fell 27.0% year-over-year to 28.16%; the TTM figure through Mar 2026 stood at 33.58% (up 495.0% YoY), while the FY2025 annual figure was 33.75%, up 671.0% from the prior year.
• EBIT Margin came in at 28.16% for Q1 2026 at Sotera Health, down from 35.73% in the prior quarter.
• The five-year high for EBIT Margin was 36.7% in Q3 2025, with the low at 15.13% in Q1 2023.
• Average EBIT Margin over 5 years is 27.69%, with a median of 28.16% recorded in 2026.
• The largest YoY upside for EBIT Margin was 962 bps in 2023 against a maximum downside of 747 bps in 2023.
• Year by year, EBIT Margin stood at 23.92% in 2022, then soared by 40 bps to 33.53% in 2023, then dropped by 10 bps to 30.03% in 2024, then gained by 19 bps to 35.73% in 2025, then dropped by 21 bps to 28.16% in 2026.
• According to Business Quant data, EBIT Margin over the past three periods registered 28.16%, 35.73%, and 36.7% for Q1 2026, Q4 2025, and Q3 2025 respectively.